Engel classification
Engel Classification[edit | edit source]
The Engel classification is a system used to categorize the outcomes of epilepsy surgery. It was developed by Dr. Jerome Engel, a prominent neurologist, to provide a standardized way to assess the success of surgical interventions in patients with epilepsy. The classification is widely used in clinical practice and research to evaluate the effectiveness of surgical treatments for epilepsy.
Classification System[edit | edit source]
The Engel classification consists of four main categories, each describing a different level of seizure control achieved after surgery:
- Engel Class I: Patients in this category experience freedom from disabling seizures. This is considered the best possible outcome, indicating that the surgery was highly successful in controlling the patient's epilepsy.
- Engel Class II: Patients in this category have rare disabling seizures. While not completely seizure-free, these patients experience a significant reduction in seizure frequency and severity.
- Engel Class III: Patients in this category have worthwhile improvement. They experience a reduction in seizure frequency, but still have more than rare disabling seizures.
- Engel Class IV: Patients in this category have no worthwhile improvement. The surgery did not significantly reduce the frequency or severity of seizures.
Application[edit | edit source]
The Engel classification is applied during follow-up assessments after epilepsy surgery. It helps clinicians and researchers to:
- Evaluate the long-term effectiveness of surgical interventions.
- Compare outcomes across different surgical techniques and patient populations.
- Guide future treatment decisions for patients with epilepsy.
Limitations[edit | edit source]
While the Engel classification is a valuable tool, it has some limitations:
- It primarily focuses on seizure frequency and does not account for other factors such as quality of life or medication use.
- The classification is subjective and relies on patient self-reporting and clinical judgment.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
